Cite
APA Citation
Cardenas, M., Font, P., De La Fuente-Ruiz, S., Viguera-Guerra, I., Casado, M., Castro-Villegas, M., Calvo-Gutierrez, J., & Collantes-Estevez, E. (n.d.). cP-061 Long-term cost-effectiveness analysis of infliximab, etanercept and adalimumab in rheumatoid arthritis patients in real-life clinical practice. European journal of hospital pharmacy, 22, A24. http://access.bl.uk/ark:/81055/vdc_100172521815.0x00001a